Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU

Mise à jour : Il y a 4 ans
Référence : NCT01999777

Femme et Homme

Extrait

This study is designed to evaluate the efficacy, safety, and tolerability of USL261 compared with that of intranasal (IN) placebo for the treatment of intermittent bouts of increased seizure activity.


Critère d'inclusion

  • Epilepsy


Liens